Literature DB >> 25870215

Anti-VEGF therapy in a silicone oil-filled myopic eye with choroidal neovascularisation.

Jay Chhablani1, Raja Narayanan1.   

Abstract

A 33-year-old man presented with vision loss in his right eye due to rhegmatogenous retinal detachment, for which he underwent pars plana vitrectomy with silicone oil injection. Three months later, the patient presented with sudden vision loss. On examination, his visual acuity was 20/200 with presence of subretinal haemorrhage with attached retina and silicone oil in situ. Fluorescein angiography confirmed the diagnosis of choroidal neovascularisation (CNV). The patient underwent intravitreal ranibizumab injection (0.5 mg per 0.05 mL). He subsequently underwent oil removal along with intravitreal bevacizumab injection (1.25 mg per 0.05 mL). The CNV completely regressed. At 7 years follow-up, the patient's best corrected visual acuity was 20/50 with attached retina and macular scar due to regressed CNV. His other eye was within normal limits throughout the follow-up period. This unique case demonstrates the successful outcome of intravitreal ranibizumab injection in a silicone oil-filled eye with myopic CNV. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25870215      PMCID: PMC4401942          DOI: 10.1136/bcr-2014-208663

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  4 in total

1.  Ocular pharmacokinetics of bevacizumab in vitrectomized eyes with silicone oil tamponade.

Authors:  Yu Xu; Yongsheng You; Wennan Du; Chunhui Zhao; Jie Li; Jianbo Mao; Hao Chen; Lingyun Cheng
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-08-07       Impact factor: 4.799

2.  Therapeutic effect of bevacizumab injected into the silicone oil in eyes with neovascular glaucoma after vitrectomy for advanced diabetic retinopathy.

Authors:  K Ghasemi Falavarjani; M Modarres; H Nazari
Journal:  Eye (Lond)       Date:  2010-04       Impact factor: 3.775

3.  Intrasilicone bevacizumab injection for iris neovascularization after vitrectomy for proliferative diabetic retinopathy.

Authors:  Abdelrahman G Salman
Journal:  Ophthalmic Res       Date:  2012-09-13       Impact factor: 2.892

4.  Intravitreal Ranibizumab for myopic choroidal neovascularization after pars plana vitrectomy and silicone oil tamponade.

Authors:  Maria Lucia Cascavilla; Giuseppe Querques; Lea Querques; Marco Codenotti; Francesco Bandello
Journal:  Eur J Ophthalmol       Date:  2013-06-23       Impact factor: 2.597

  4 in total
  1 in total

1.  Concurrent management of myopic choroidal neovascularization and rhegmatogenous retinal detachment with intravitreal antivascular endothelial growth factor during primary retinal detachment repair.

Authors:  Kumar Saurabh; Rupak Roy; Nicey Roy Thomas; Maitreyi Chowdhury
Journal:  Indian J Ophthalmol       Date:  2018-03       Impact factor: 1.848

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.